LRRK2: An Emerging New Molecule in the Enteric Neuronal System That Quantitatively Regulates Neuronal Peptides and IgA in the Gut

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Digestive Diseases and Sciences

• Publication date

  2017-02-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10620-017-4476-3PMID 28168579
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Leucine-rich repeat kinase 2 is a regulator of B cell function, affecting homeostasis, BCR signaling, IgA production, and TI antigen responses.

  2016cited by this paper
• Commensal bacteria direct selective cargo sorting to promote symbiosis

  2015cited by this paper
• Insights into the Role of Erysipelotrichaceae in the Human Host

  2015cited by this paper
• Lactoferrin Combined with Retinoic Acid Stimulates B1 Cells to Express IgA Isotype and Gut-homing Molecules

  2015cited by this paper
• Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis.

  2015cited by this paper
• The Enteric Glia: Identity and Functions

  2015cited by this paper
• LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis.

  2014cited by this paper
• Inhibition of Vasoactive Intestinal Polypeptide (VIP) Induces Resistance to Dextran Sodium Sulfate (DSS)-Induced Colitis in Mice

  2014cited by this paper
• Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents

  2014cited by this paper
• LRRK2 pathobiology in Parkinson's disease

  2014cited by this paper
• Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression.

  2013cited by this paper
• Short- and Long-Term Effects of LRRK2 on Axon and Dendrite Growth

  2013cited by this paper
• Emerging neuropeptide targets in inflammation: NPY and VIP.

  2013cited by this paper
• The digestive neuronal–glial–epithelial unit: a new actor in gut health and disease

  2013cited by this paper
• Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies

  2013cited by this paper
• Paradoxical regulation of ChAT and nNOS expression in animal models of Crohn's colitis and ulcerative colitis.

  2013cited by this paper
• LRRK2 Inhibition Attenuates Microglial Inflammatory Responses

  2012cited by this paper
• LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors

  2012cited by this paper
• LRRK2 Phosphorylates Tubulin-Associated Tau but Not the Free Molecule: LRRK2-Mediated Regulation of the Tau-Tubulin Association and Neurite Outgrowth

  2012cited by this paper
• The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease

  2011cited by this paper
• Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures

  2011cited by this paper
• Enteric neuronal density contributes to the severity of intestinal inflammation.

  2011cited by this paper
• Roles of B‐1 and B‐2 cells in innate and acquired IgA‐mediated immunity

  2010cited by this paper
• LRRK2 is expressed in B-2 but not in B-1 B cells, and downregulated by cellular activation.

  2010cited by this paper
• Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

  2010cited by this paper
• Genomewide association study of leprosy.

  2009cited by this paper
• Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

  2008cited by this paper
• Intestinal Bacteria Condition Dendritic Cells to Promote IgA Production

  2008cited by this paper
• Differentiation and homing of IgA-secreting cells

  2008cited by this paper
• RNA interference of LRRK2–microarray expression analysis of a Parkinson’s disease key player

  2008cited by this paper
• The immune geography of IgA induction and function

  2008cited by this paper
• Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn's disease.

  2007cited by this paper
• Expression and localization of Parkinson's disease‐associated leucine‐rich repeat kinase 2 in the mouse brain

  2007cited by this paper
• IL-13 receptor alpha2 promotes epithelial cell regeneration from radiation-induced small intestinal injury in mice.

  2006cited by this paper
• Localization of LRRK2 to membranous and vesicular structures in mammalian brain

  2006cited by this paper
• Control of gastrointestinal motility by the "gut brain"--the enteric nervous system.

  2005cited by this paper
• The RIP kinases: crucial integrators of cellular stress.

  2005cited by this paper
• An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family

  2005cited by this paper
• Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.

  2004cited by this paper
• Interactions between the enteric nervous system and the immune system: role of neuropeptides and nutrition.

  2003cited by this paper
• A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2–q13.1

  2002cited by this paper
• Types of neurons in the enteric nervous system.

  2000cited by this paper
• Vasoactive intestinal peptide induces S(alpha)/S(mu) switch circular DNA in human B cells.

  1996cited by this paper
• Substance P promotes Peyer's patch and splenic B cell differentiation.

  1995cited by this paper
• Vasoactive intestinal peptide stimulates immunoglobulin production and growth of human B cells

  1992cited by this paper
• Substance P acts directly upon cloned B lymphoma cells to enhance IgA and IgM production.

  1991cited by this paper
• Vasoactive intestinal peptide as a laboratory supplement to clinical activity index in inflammatory bowel disease

  1989cited by this paper
• Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen.

  1986cited by this paper
• Mucosal barrier mechanisms. Interplay between secretory IgA (SIgA), IgG and mucins on the surface properties and association of salmonellae with intestine and granulocytes.

  1982cited by this paper

• Deficiency of leucine-rich repeat kinase 2 aggravates thioacetamide-induced acute liver failure and hepatic encephalopathy in mice

  2024cites this paper
• Biphenotypic Cells and α-Synuclein Accumulation in Enteric Neurons of Leucine-Rich Repeat Kinase 2 Knockout Mice

  2024influential citation
• Are LRRK2 mysteries lurking in the gut?

  2023cites this paper
• Mild Chronic Colitis Triggers Parkinsonism in LRRK2 Mutant Mice through Activating TNF‐α Pathway

  2022cites this paper
• Reply to: Mild Chronic Colitis Triggers Parkinsonism in LRRK2 Mutant Mice through Activating TNF‐α Pathway

  2022cites this paper
• RNA-seq analysis of gene expression profiles in posttraumatic stress disorder, Parkinson’s disease and schizophrenia identifies roles for common and distinct biological pathways

  2022cites this paper
• Parkinson’s disease and cancer: a systematic review and meta-analysis on the influence of lifestyle habits, genetic variants, and gender

  2022cites this paper
• Peripheral Blood DNA Methylation Profiles Do Not Predict Endoscopic Post-Operative Recurrence in Crohn’s Disease Patients

  2022cites this paper
• Single‐Trajectory Multiple Target for Parkinsonian Mobility and Cognition? An Inadvisable Idea

  2022cites this paper
• LRRK2 expression in normal and pathologic human gut and in rodent enteric neural cell lines

  2022cites this paper
• LRRK2 is reduced in Parkinson’s disease gut

  2021cites this paper
• New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota

  2021influential citation
• Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links

  2020cites this paper
• The Current State-of-the Art of LRRK2-Based Biomarker Assay Development in Parkinson’s Disease

  2020cites this paper
• LRRK2 Parkinsonism: Does the Response to Gut Bacteria Mitigate the Neurological Picture?

  2020cites this paper
• Leucine-Rich Repeat Kinase 2 Is Associated With Activation of the Paraventricular Nucleus of the Hypothalamus and Stress-Related Gastrointestinal Dysmotility

  2019cites this paper
• Response of Beef Cattle Fecal Microbiota to Grazing on Toxic Tall Fescue

  2019cites this paper
• Beef cattle fecal microbiota response to toxic tall fescue grazing 1

  2019cites this paper
• Exosome/microvesicle content is altered in leucine‐rich repeat kinase 2 mutant induced pluripotent stem cell‐derived neural cells

  2019cites this paper
• LRRK2 regulation of immune-pathways and inflammatory disease

  2019cites this paper
• LRRK2 Expression in the Enteric Nervous System: ENSuring Its Significance

  2017cites this paper